| Application no. and date | 02788214.1 (espacenet) (Federated) (European Patent Register), 20021220 | | Patent/reg. no. and date | DK/EP 1463506, 20091021 | | Publication date | 20041006 | | Priority no. and date | EP 01403357, 20011224 | | EP pub. no. and date |
EP 1463506 20041006 | | Effective date | | | Applicant/owner | Astrazeneca AB, S-151 85 Sodertalje, SE | | Applicant ref. no. | AST 100607-1X | | Inventor | JUNG, Frederic Henri, Z.I. la pompelle,
BP 1050
Cedex 2, 51689 Reims, FR,
PASQUET, Georges Rene, Z.I. la pompelle,
BP 1050
Cedex 2, 51689 Reims, FR | | Representative | | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , C07D 401/14 (2006.01) , C07D 403/12 (2006.01) , C07D 403/14 (2006.01) | | Title | Substituerede quinazolin-derivater som inhibitorer af aurora-kinaser | | Int. application no. | GB2002005845 | | Int. publication no. | WO2003055491 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
